These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23333936)

  • 21. Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.
    Hack CC; Stoll MJ; Jud SM; Heusinger K; Adler W; Haeberle L; Ganslandt T; Heindl F; Schulz-Wendtland R; Cavallaro A; Uder M; Beckmann MW; Fasching PA; Bayer CM
    Cancer Med; 2017 Jun; 6(6):1473-1481. PubMed ID: 28464481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic differences in mammographic densities: an Asian cross-sectional study.
    Mariapun S; Li J; Yip CH; Taib NA; Teo SH
    PLoS One; 2015; 10(2):e0117568. PubMed ID: 25659139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes.
    Fjeldheim FN; Frydenberg H; Flote VG; McTiernan A; Furberg AS; Ellison PT; Barrett ES; Wilsgaard T; Jasienska G; Ursin G; Wist EA; Thune I
    BMC Cancer; 2016 Oct; 16(1):776. PubMed ID: 27717337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of mammographic density among women with a strong family history of breast cancer.
    Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
    BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer.
    Rauh C; Hack CC; Häberle L; Hein A; Engel A; Schrauder MG; Fasching PA; Jud SM; Ekici AB; Loehberg CR; Meier-Meitinger M; Ozan S; Schulz-Wendtland R; Uder M; Hartmann A; Wachter DL; Beckmann MW; Heusinger K
    Geburtshilfe Frauenheilkd; 2012 Aug; 72(8):727-733. PubMed ID: 25258465
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study.
    Chen Y; Dawes PT; Packham JC; Mattey DL
    Arthritis Res Ther; 2012 Apr; 14(2):R81. PubMed ID: 22513132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction.
    Lee CP; Choi H; Soo KC; Tan MH; Chay WY; Chia KS; Liu J; Li J; Hartman M
    PLoS One; 2015; 10(9):e0136650. PubMed ID: 26401662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission analysis of TGFB1 gene polymorphisms in non-syndromic cleft lip with or without cleft palate.
    Raju GT; Lakkakula BVKS; Murthy J; Kannan MA; Paul SFD
    Int J Pediatr Otorhinolaryngol; 2017 Sep; 100():14-17. PubMed ID: 28802359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study.
    Warner ET; Rice MS; Zeleznik OA; Fowler EE; Murthy D; Vachon CM; Bertrand KA; Rosner BA; Heine J; Tamimi RM
    NPJ Breast Cancer; 2021 May; 7(1):68. PubMed ID: 34059687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound.
    Häberle L; Hack CC; Heusinger K; Wagner F; Jud SM; Uder M; Beckmann MW; Schulz-Wendtland R; Wittenberg T; Fasching PA
    Eur J Med Res; 2017 Aug; 22(1):30. PubMed ID: 28854966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Diao P; Nielsen MB; Uldall WY; Vejborg I
    BMC Cancer; 2015 Apr; 15():274. PubMed ID: 25884160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.
    Hadj-Ahmed M; Ghali RM; Bouaziz H; Habel A; Stayoussef M; Ayedi M; Hachiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
    Tumour Biol; 2019 Aug; 41(8):1010428319869096. PubMed ID: 31405342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.
    Verheus M; Maskarinec G; Woolcott CG; Haiman CA; Le Marchand L; Henderson BE; Cheng I; Kolonel LN
    Int J Cancer; 2010 Sep; 127(5):1115-23. PubMed ID: 20039319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammographic breast density in women with premature ovarian failure: a prospective analysis.
    Benetti-Pinto CL; Brancalion MF; Assis LH; Tinois E; Giraldo HP; Cabello C; Yela DA
    Menopause; 2014 Sep; 21(9):933-7. PubMed ID: 24518154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study.
    Stuedal A; Ursin G; Veierød MB; Bremnes Y; Reseland JE; Drevon CA; Gram IT
    Breast Cancer Res; 2006; 8(5):R55. PubMed ID: 17010200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia.
    Saltzman BS; Yamamoto JF; Decker R; Yokochi L; Theriault AG; Vogt TM; Le Marchand L
    Cancer Res; 2008 Feb; 68(4):1236-44. PubMed ID: 18281501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
    Grigorova A; Trenova A; Stanilova S
    Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene variations in oestrogen pathways, CYP19A1, daily 17β-estradiol and mammographic density phenotypes in premenopausal women.
    Flote VG; Furberg AS; McTiernan A; Frydenberg H; Ursin G; Iversen A; Lofteroed T; Ellison PT; Wist EA; Egeland T; Wilsgaard T; Makar KW; Chang-Claude J; Thune I
    Breast Cancer Res; 2014 Dec; 16(6):499. PubMed ID: 25522654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China.
    Chen XH; Li XQ; Chen Y; Feng YM
    Breast Cancer Res Treat; 2011 Jan; 125(2):575-82. PubMed ID: 20640597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.